Literature DB >> 3927859

Gm and Km allotypes in rheumatoid arthritis.

P A Sanders, G G de Lange, P A Dyer, D M Grennan.   

Abstract

Immunoglobulin heavy chain (Gm) and kappa light chain (Km) allotype and phenotype frequencies were compared in 173 patients with rheumatoid arthritis (RA) and in 798 controls. No significant differences were found between allotype or phenotype frequencies in overall RA and control groups. However, the Gm(zaxfngb) phenotype and G1m(x) allotype were increased in HLA-DR4 positive RA patients compared with DR4 negative patients and controls, suggesting that immunoglobulin heavy chain genes interact with HLA in the pathogenesis of RA. All four patients with pulmonary fibrosis were Km(1) positive suggesting a possible role for immunoglobulin kappa light chain genes in the pathogenesis of pulmonary fibrosis found in rheumatoid patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3927859      PMCID: PMC1001696          DOI: 10.1136/ard.44.8.529

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

1.  Correlation of Gm allotype, antibody response, and mortality.

Authors:  I R Mackay; J V Wells; H H Fudenberg
Journal:  Clin Immunol Immunopathol       Date:  1975-01

2.  Incidence of the Gm serum groups in collagen diseases.

Authors:  A TIILIKAINEN
Journal:  Ann Med Exp Biol Fenn       Date:  1960

3.  Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors:  A Larsen; K Dale; M Eek
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-07

4.  Gm phenotypes in autoimmune thyroid disease.

Authors:  N R Farid; R M Newton; E P Noel; W H Marshall
Journal:  J Immunogenet       Date:  1977-12

5.  Genes for immunoglobulin heavy chains and for alpha 1-antitrypsin are localized to specific regions of chromosome 14q.

Authors:  D W Cox; V D Markovic; I E Teshima
Journal:  Nature       Date:  1982-06-03       Impact factor: 49.962

6.  Interaction of HLA and Gm in autoimmune chronic active hepatitis.

Authors:  S Whittingham; J D Mathews; M S Schanfield; B D Tait; I R Mackay
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

7.  The Gm and Inv factors in rheumatoid arthritis.

Authors:  A Archimandritis; A Kalos; G Papakonstantinou; A Babionitakis; G Theodoropoulos; P Dimitriadis
Journal:  Acta Genet Med Gemellol (Roma)       Date:  1975

8.  Types of serum proteins and erythrocyte enzymes in rheumatoid patients.

Authors:  D Schlesinger; J Hałasa; M Mańczak; D Sotnik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1978       Impact factor: 4.291

9.  IgG heavy chain allotypes (Gm) in autoimmune diseases.

Authors:  Y Nakao; H Matsumoto; T Miyazaki; H Nishitani; K Takatsuki; R Kasukawa; S Nakayama; S Izumi; T Fujita; K Tsuji
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

10.  alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis.

Authors:  D M Geddes; M Webley; D A Brewerton; C W Turton; M Turner-Warwick; A H Murphy; A M Ward
Journal:  Lancet       Date:  1977-11-19       Impact factor: 79.321

View more
  14 in total

Review 1.  Gm allotype system and autoimmune diseases.

Authors:  M Abu-Shakra; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Alpha 1 antitrypsin (PI) phenotypes in two rheumatic diseases: a reappraisal of the association of PI subtypes in rheumatoid arthritis.

Authors:  S S Papiha; B Pal; D Walker; P Mangion; M A Hossain
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

3.  HLA haplotype sharing by siblings with rheumatoid arthritis: evidence for genetic heterogeneity.

Authors:  D M Grennan; P A Sanders; P A Dyer; R Harris
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

4.  Immunoglobulin lambda light chain genes in rheumatoid arthritis.

Authors:  D Sidebottom; D M Grennan; P A Sanders; A Read
Journal:  Ann Rheum Dis       Date:  1987-08       Impact factor: 19.103

5.  Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.

Authors:  C N Gaiser; M J Johnson; G de Lange; L Rassenti; L L Cavalli-Sforza; L Steinman
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

6.  HLA-linked rheumatoid arthritis.

Authors:  S J Hasstedt; D O Clegg; L Ingles; R H Ward
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

7.  Immunoglobulin allotype Gm(1,2;21) in ankylosing spondylitis with peripheral arthritis.

Authors:  R Mierau; C A von Mühlen; H Zarnowski; E Genth; P W Hartl
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

8.  Chromosome 14 markers in rheumatoid arthritis.

Authors:  W Ollier; W Thomson; S Welch; G G de Lange; A Silman
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

9.  Immunogenetic studies in families with rheumatoid arthritis and autoimmune thyroid disease.

Authors:  P A Sanders; D M Grennan; P A Dyer; G G de Lange; R Harris
Journal:  J Med Genet       Date:  1985-12       Impact factor: 6.318

10.  Gm allotypes and HLA in rheumatoid arthritis patients with circulating antibodies to native type II collagen.

Authors:  P A Sanders; D M Grennan; P S Klimiuk; R B Clague; G G deLange; I Collins; P A Dyer
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.